![Seonghwan Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seonghwan Lee
Direktor/Vorstandsmitglied bei Orange Grove Bio LLC
Aktive Positionen von Seonghwan Lee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SV Investment Corp/US/ | Private Equity Investor | 01.03.2020 | - |
Orange Grove Bio LLC
![]() Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.11.2022 | - |
Karriereverlauf von Seonghwan Lee
Ausbildung von Seonghwan Lee
Harvard Business School | Masters Business Admin |
Yonsei University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Südkorea | 2 |
Operativ
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Private Equity Investor | 1 |
Sektoral
Consumer Services | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
SV Investment Corp/US/ | Finance |
Orange Grove Bio LLC
![]() Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Finance |
- Börse
- Insiders
- Seonghwan Lee
- Erfahrung